Fingerprint
Dive into the research topics of 'Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation
- Philip G. Thomas
- , Kenneth J. Woodside
- , Jacqueline A. Lappin
- , Smita Vaidya
- , Srinivasan Rajaraman
- , Kristene K. Gugliuzza
Research output: Contribution to journal › Article › peer-review
68
Scopus
citations